Researchers have developed engineered heart muscle allografts from stem cells, showing promising results in repairing heart ...

At the Third International Summit on Human Genome Editing, held in March 2023 at the Francis Crick Institute in London, ...

Gladstone Institutes is weighing buying a newly built Mission Bay space. But it’s also working to expand its headquarters ...

Injections into injured joints and tissues have exploded in the last decade. Though they all seem to work, here are some of what we don’t know. Joint injections used to be either cortisone or ...

If you’ve been on the internet recently, you’ve likely encountered Bryan Johnson’s meticulously optimized, data-driven quest ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

In celebration of the 10th anniversary of the United Nations' International Day of Women and Girls in Science on 11th February 2025, AMSBIO sat down with Dr Zoe Hewitt, a leading expert in cell ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

Creative Medical Technology (CELZ) announced an expanded agreement with Greenstone Biosciences to leverage Artificial Intelligence in further ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...